Laparoscopic Power Morcellators Market, By Application (Hysterectomy, Myomectomy, and Others), By End User (Hospitals and Clinics and Surgical Centers), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : May 2024

Code : CMI4905

Pages :196

Formats :

Excel and PDF

Industry : Medical Devices

Market Challenge – Increasing Product Recalls by Regulatory Authorities

Increasing product recalls from regulatory authorities is expected to hamper the growth of the global laparoscopic power morcellators market over the forecast period. For instance, on October 26, 2021, the U.S. Food and Drug Administration (FDA) issued a recall notice for the PneumoLiner device which is intended for use as a tissue containment system during minimally invasive gynecologic laparoscopic surgery, manufactured by Olympus Corporation has received recall notification from the U.S. Food and Drug Administration (FDA) due to manufacturing error.

Market Opportunity – Emerging Markets in Developing Countries

The laparoscopic power morcellators market in emerging markets of developing countries presents a great opportunity for growth. These emerging markets are undergoing rapid urbanization and economic development which is leading to a rise in disposable incomes. As incomes rise, access to healthcare and elective surgical procedures is also increasing. Emerging markets present a unique growth opportunity for laparoscopic power morcellator suppliers. Establishing local manufacturing and distribution networks to cater to these markets early will allow companies to gain a first-mover advantage and build brand loyalty as demand is set to exponentially rise in the coming years due to favorable socioeconomic conditions. This can help power continued leadership in the global morcellators market over the long term.